Clinical trial

Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Early Stage, Low Volume Prostate Cancer

NCT01354951

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2011-05-01

PhasePHASE2

Study timeline

Study start (unknown)2011-05-01Date precision: month

Registry last updated2018-10-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

Prostate Biopsy, Focal Brachytherapy , Assessment of QOLOTHER

Sponsors & collaborators

Memorial Sloan Kettering Cancer Centerlead sponsor

University of Colorado, Denvercollaborator

M.D. Anderson Cancer Centercollaborator

Northwell Healthcollaborator

Mapped research locations

New YorkNew York, United States1 HoustonTexas, United States1 New Hyde ParkNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01354951 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.